Nucleophosmin (NPM1) Mutation Analysis, Varies-994
Test info
NPM1 MRD
Nucleophosmin Mutation Analysis
As a prognostic indicator in patients with newly diagnosed acute myelogenous leukemia with normal karyotype and no FLT3 variant and as a leukemia-specific marker of minimal residual disease
Specimen
Immediatley following collection, mix sample by inverting 8 - 10 times to prevent clotting
Do not spin; Send specimen in original tube.
Lavender (EDTA), 4mL
or
Yellow ACD-B
Immediatley following collection, mix sample by inverting 8 - 10 times to prevent clotting
Do not spin; Send specimen in original tube.
Lavender (EDTA), 4 mL
Yellow ACD-B
Molecular Medicare Billing Request
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.
Refrigerated (preferred) - 5 days
Ambeint - 72 hours
- Gross hemolysis
- Moderately to severely clotted
- Bone marrow biopsies
- Paraffin-embedded bone marrow clots
- Slides
- Paraffin shavings
Performance
RNA: Reverse-Transcription Quantitative PCR (RT-qPCR)
DNA: Polymerase Chain Reaction (PCR) with Fragment Analysis by Capillary Gel Electrophoresis
Clinical and Interpretive info
See report
Billing
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.